ZNF33B Activators
The class of chemicals listed as ZNF33B Activators includes various compounds that indirectly influence ZNF33B through their effects on epigenetic regulation and gene expression. These compounds are not direct activators of ZNF33B but may impact its function by modulating the cellular environment and processes related to transcriptional regulation.DNA methyltransferase inhibitors like 5-Azacytidine and Decitabine can alter epigenetic marks, influencing gene expression patterns where ZNF33B is involved. Histone deacetylase inhibitors, such as Trichostatin A, SAHA, Valproic Acid, Panobinostat, Romidepsin, Mocetinostat, and Entinostat, modify the chromatin landscape, thereby impacting ZNF33B function in gene regulation.
BET bromodomain inhibitors like JQ1 affect transcriptional regulation by modulating the reading of acetylation marks on histones, which could indirectly influence ZNF33B's role in gene expression.EZH2 inhibitors, such as GSK126, target the enzymatic activity of the polycomb repressive complex 2 (PRC2), involved in the trimethylation of histone H3 on lysine 27 (H3K27me3). By altering these epigenetic marks, they may indirectly affect the functionality of ZNF33B in gene regulation.Overall, while these compounds do not specifically target ZNF33B, their roles in epigenetic modulation and transcriptional regulation suggest they could have an indirect impact on the functionality of ZNF33
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, a histone deacetylase inhibitor, could indirectly impact ZNF33B function by modifying chromatin structure and gene regulation. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Decitabine, a DNA methyltransferase inhibitor, could affect ZNF33B function indirectly by modulating epigenetic landscapes. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic Acid, a histone deacetylase inhibitor, might indirectly impact ZNF33B by influencing gene expression and chromatin dynamics. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
Panobinostat, a broad-spectrum histone deacetylase inhibitor, may have an indirect effect on ZNF33B through its role in gene regulation. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
Romidepsin, a selective histone deacetylase inhibitor, could indirectly influence ZNF33B activity by modulating gene expression patterns. | ||||||
SGI-1027 | 1020149-73-8 | sc-473875 | 10 mg | $213.00 | ||
SGI-1027, a DNA methyltransferase inhibitor, might affect ZNF33B function indirectly by altering epigenetic regulation. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1, a BET bromodomain inhibitor, may influence ZNF33B activity indirectly by impacting transcription regulation. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
Mocetinostat, a histone deacetylase inhibitor, could have an indirect impact on ZNF33B through its effects on gene expression and chromatin structure. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
Entinostat, another histone deacetylase inhibitor, might influence ZNF33B function indirectly in gene regulation processes. | ||||||
GSK126 | 1346574-57-9 | sc-490133 sc-490133A sc-490133B | 1 mg 5 mg 10 mg | $92.00 $243.00 $306.00 | ||
GSK126, an EZH2 inhibitor, could affect ZNF33B indirectly by modulating chromatin remodeling and gene expression. | ||||||